2026-2034年全球心房颤动治疗设备市场规模、份额、趋势和成长分析报告

预计到 2034 年，心房颤动治疗设备的市场规模将从 2025 年的 162 亿美元增长至 445.3 亿美元，并预计从 2026 年到 2034 年将以 11.89% 的复合年增长率增长。

由于心血管疾病（尤其是常见的心律不整－心房颤动）的盛行率不断上升，全球心房颤动治疗设备市场正在快速成长。用于治疗心房颤动的装置包括心臟监测系统、消融导管和用于调节心率的植入装置。这些技术有助于改善心房颤动的诊断、治疗和长期管理。

市场成长主要受心臟病发病率上升、人口老化以及心臟治疗技术进步的推动。医疗机构正在扩大微创手术和先进医疗设备的应用，以改善心房颤动患者的治疗效果。此外，对心血管研究和医疗基础设施投入的增加也促进了该市场的扩张。

展望未来，由于医疗技术的不断进步和对有效心臟治疗需求的不断增长，心房颤动治疗设备市场预计将持续成长。电生理设备、穿戴式心率监测系统和导管介入手术的创新将进一步拓展治疗选择。公众意识的提高和诊断能力的提升预计将推动市场持续成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球心房颤动治疗设备市场：依产品分类

• 市场分析、洞察与预测
• 电生理消融导管
• 心臟监测仪或植入式循环记录仪
• 电生理诊断导管
• 地图绘製与记录系统
• 存取装置
• 经心超音波心臟检查（ICE）
• 左心耳封堵装置
• 其他产品

第五章：全球心房颤动治疗设备市场：依最终用途划分

• 市场分析、洞察与预测
• 医院
• 心臟中心
• 门诊手术中心
• 其他最终用户

第六章 全球心房颤动治疗设备市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott Laboratories
  • Acutus Medical Inc
  • AtriCure Inc
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • CardioFocus Inc
  • CathRx Ltd
  • Hansen Medical Inc
  • Imricor Medical Systems Inc
  • Johnson & Johnson（Biosense Webster）
  • Medtronic Plc
  • MicroPort Scientific Corporation
  • Osypka Medical GmbH
  • Stryker Corporation
  • Synaptic Medical

The Atrial Fibrillation Devices Market size is expected to reach USD 44.53 Billion in 2034 from USD 16.20 Billion (2025) growing at a CAGR of 11.89% during 2026-2034.

The Global Atrial Fibrillation Devices Market is growing rapidly due to the increasing prevalence of cardiovascular disorders, particularly atrial fibrillation (AF), a common heart rhythm disorder. Devices used in the management of atrial fibrillation include cardiac monitoring systems, ablation catheters, and implantable devices designed to regulate heart rhythm. These technologies help improve diagnosis, treatment, and long-term management of the condition.

Market growth is driven by the rising incidence of heart diseases, an aging population, and advancements in cardiac treatment technologies. Healthcare providers are increasingly adopting minimally invasive procedures and advanced medical devices to improve treatment outcomes for patients with atrial fibrillation. Additionally, growing investments in cardiovascular research and healthcare infrastructure are supporting the expansion of this market.

Looking forward, the atrial fibrillation devices market is expected to grow as medical technologies continue to advance and demand for effective cardiac treatments increases. Innovations in electrophysiology devices, wearable heart monitoring systems, and catheter-based procedures will further enhance treatment options. With increasing awareness and improved diagnostic capabilities, the market is projected to experience sustained growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• EP Ablation Catheters
• Cardiac Monitors or Implantable Loop Recorder
• EP Diagnostic Catheters
• Mapping and Recording Systems
• Access Devices
• Intracardiac Echocardiography (ICE)
• Left Atrial Appendage (LAA) Closure Devices
• Other Products

By End Use

• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers
• Other End Users

COMPANIES PROFILED

• Abbott Laboratories, Acutus Medical Inc, AtriCure Inc, Biotronik SE Co KG, Boston Scientific Corporation, CardioFocus Inc, CathRx Ltd, Hansen Medical Inc, Imricor Medical Systems Inc, Johnson Johnson Biosense Webster, Medtronic plc, MicroPort Scientific Corporation, Osypka Medical GmbH, Stryker Corporation, Synaptic Medical
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. EP Ablation Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Cardiac Monitors or Implantable Loop Recorder Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. EP Diagnostic Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Mapping and Recording Systems Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Access Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Intracardiac Echocardiography (ICE) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Left Atrial Appendage (LAA) Closure Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Other Products Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET: BY END USE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End Use
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Cardiac Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ATRIAL FIBRILLATION DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product
  • 6.2.2 By End Use
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product
  • 6.3.2 By End Use
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product
  • 6.4.2 By End Use
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product
  • 6.5.2 By End Use
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product
  • 6.6.2 By End Use
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL ATRIAL FIBRILLATION DEVICES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Abbott Laboratories
  • 8.2.2 Acutus Medical Inc
  • 8.2.3 AtriCure Inc
  • 8.2.4 Biotronik SE & Co. KG
  • 8.2.5 Boston Scientific Corporation
  • 8.2.6 CardioFocus Inc
  • 8.2.7 CathRx Ltd
  • 8.2.8 Hansen Medical Inc
  • 8.2.9 Imricor Medical Systems Inc
  • 8.2.10 Johnson & Johnson (Biosense Webster)
  • 8.2.11 Medtronic Plc
  • 8.2.12 MicroPort Scientific Corporation
  • 8.2.13 Osypka Medical GmbH
  • 8.2.14 Stryker Corporation
  • 8.2.15 Synaptic Medical